Dysregulation of dopaminergic regulatory mechanisms in the mesolimbic pathway induced by morphine and morphine withdrawal

Brain Structure and Function

Volumn 220, Issue 4, 2015, Pages 1901-1919

  García Pérez, Daniel ^a,b   López Bellido, Roger ^c   Rodríguez, Raquel E ^c   Laorden, M Luisa ^a,b   Núñez, Cristina ^a,b   Milanés, M Victoria ^a,b  

^a UNIVERSITY OF MURCIA   (Spain)

^b Instituto Murciano de Investigacion Biosanitaria IMIB   (Spain)

^c UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Dopamine; Morphine dependence and withdrawal; Nucleus accumbens; Nurr1; Pitx3; Tyrosine hydroxylase; Ventral tegmental area

Indexed keywords

DOPAMINE; MORPHINE; NUCLEAR RECEPTOR RELATED FACTOR 1; TRANSCRIPTION FACTOR PITX3; TYROSINE 3 MONOOXYGENASE; 3,4 DIHYDROXYPHENYLACETIC ACID; HOMEODOMAIN PROTEIN; MESSENGER RNA; NALOXONE; NARCOTIC AGENT; NARCOTIC ANTAGONIST; NR4A2 PROTEIN, RAT; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; MORPHINE ADDICTION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; TURNOVER TIME; VENTRAL TEGMENTUM; WESTERN BLOTTING; WITHDRAWAL SYNDROME; ANALYSIS OF VARIANCE; ANIMAL; CONFOCAL MICROSCOPY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; THREE DIMENSIONAL IMAGING; WISTAR RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANALYSIS OF VARIANCE; ANIMALS; DISEASE MODELS, ANIMAL; DOPAMINE; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; IMAGING, THREE-DIMENSIONAL; MALE; MICROSCOPY, CONFOCAL; MORPHINE; MORPHINE DEPENDENCE; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; RATS; RATS, WISTAR; RNA, MESSENGER; TRANSCRIPTION FACTORS; TYROSINE 3-MONOOXYGENASE; VENTRAL TEGMENTAL AREA;

EID: 84933182704     PISSN: 18632653     EISSN: 18632661     Source Type: Journal    
DOI: 10.1007/s00429-014-0761-5     Document Type: Article

References (47)

1. Compton WM, Volkow ND (2006) Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend 81:103–107
2. Di Chiara G, Bassareo V (2007) Reward system and addiction: what dopamine does and doesn’t do. Curr Opin Pharmacol 7:69–76
3. Dunn KW, Kamocka MM, MacDonald JH (2011) A practical guide to evaluating colocalization in biological microscopy. Am J Physiol Cell Physiol 300:C723–C742
4. Frenois F, Cador M, Caille S, Stinus L, Le Moine C (2002) Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal. Eur J Neurosci 16:1377–1389
5. García-Pérez D, Laorden ML, Milanes MV, Níñez C (2012) Glucocorticoids regulation of FosB/DFosB expression induced by chronic opiate exposure in the brain stress system. PLoS One 7:e50264
6. García-Pérez D, López-Bellido R, Hidalgo JM, Rodriguez RE, Laorden ML, Núñez C, Milanés MV (2013a) Morphine regulates Argonaute 2 and TH expression and activity but not miR-133b in midbrain dopaminergic neurons. Addict Biol. doi:10.1111/adb.12083
7. García-Pérez D, Sáez-Belmonte F, Laorden ML, Núñez C, Milanés MV, Milanés MV (2013b) Morphine administration modulates expression of Argonaute 2 and dopamine-related transcription factors involved in midbrain dopaminergic neurons function. Br J Pharmacol 168:1889–1901
8. Georges F, Le Moine C, Aston-Jones G (2006) No effects of morphine on ventral tegmental dopamine neurons during withdrawal. J Neurosci 26:5720–5726
9. Horvath MC, Kovacs GG, Kovari V, Majtenyi K, Hurd YL, Keller E (2007) Heroin abuse is characterized by discrete mesolimbic dopamine and opioid abnormalities and exaggerated nuclear receptor-related 1 transcriptional decline with age. J Neurosci 27:13371–13375
10. Houshyar H, Manalo S, Dallman MF (2004) Time-dependent alterations in mRNA expression of brain neuropeptides regulating energy balance and hypothalamo-pituitary-adrenal activity after withdrawal from intermittent morphine treatment. J Neurosci 24:9414–9424
11. Hwang DY, Hong S, Jeong JW, Choi S, Kim H, Kim J, Kim KS (2009) Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neurons. J Neurochem 111:1202–1212
12. Hyman SE, Malenka RC, Nestler EJ (2006) Neural mechanisms of addiction: the role of reward-related learning and memory. Ann Rev Neurosci 29:565–598
13. Ikemoto S (2007) Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res Brain Res Rev 56:27–78
14. Jacobs FMJ, van der Linden AJA, Wang Y, von Oerthel L, Sul HS, Burbach JPH, Smidt MP (2009a) Identification of Dlk1, Ptpru and Klhl1 as novel Nurr1 target genes in meso-diencephalic dopamine neurons. Development 136:2363–2373
15. Jacobs FMJ, van Erp S, van der Linden AJA, von Oerthel L, Burbach JP, Smidt MP (2009b) Pitx3 potentiates Nurr1 in dopamine neuron terminal differentiation through release of SMRT-mediated repression. Development 136:531–540
16. Jankovic J, Chen S, Le WD (2005) The role of Nurr1 in the development of dopaminergic neurons and Parkinson’s disease. Prog Neurobiol 77:128–138
17. Johnson SW, North RA (1992) Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12:483–488
18. Kadkhodaei B, Ito T, Joodmardi E, Mattsson B, Rouillard C, Carta M, Muramatsu SI, Sumi-Ichinose C, Nomura T, Metzger D, Chambon P, Lindqvist E, Larsson NG, Olson L, Björklund A, Ichinose H, Perlmann T (2009) Nurr1 is required for maintenance of maturing and adult midbrain dopamine neurons. J Neurosci 29:15923–15932
19. Kalivas PW, Volkow ND (2005) The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162:1403–1413
20. Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E, Hannon G, Abeliovich A (2007) A microRNA feedback circuit in midbrain dopamine neurons. Science 317:1220–1224
21. Lammel S, Lim BK, Ran C, Betley MJ, Tye KM, Malenka RC (2012) Input-specific control of reward and aversion in the ventral tegmental area. Nature 491:212–217
22. Lammel S, Lim BK, Malenka RC (2014) Reward and aversion in a heterogeneous midbrain dopamine system. Neuropharmacology 76(Part B):351–359
23. Leng A, Feldon J, Ferger B (2004) Long-term social isolation and medial prefrontal cortex: dopaminergic and cholinergic neurotransmission. Pharmacol Biochem Behav 77:371–379
24. Leo D, di Porzio U, Racagni G, Riva MA, Fumagalli F, Perrone-Capano C (2007) Chronic cocaine administration modulates the expression of transcription factors involved in midbrain dopaminergic neuron function. Exp Neurol 203:472–480
25. Lu P, Vogel C, Wang R, Yao X, Marcotte EM (2007) Absolute protein expression profiling estimates the relative contributions of transcriptional and translational regulation. Nat Biotech 25:117–124
26. Matthes HWD, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, Dolle P, Tzavara E, Hanoune J, Roques B, Kieffer BL (1996) Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the [micro]-opioid-receptor gene. Nature 383:819–823
27. Mazei-Robison MS, Nestler EJ (2012) Opiate-induced molecular and cellular plasticity of ventral tegmental area and locus coeruleus catecholamine neurons. Cold Spring Harb Perspect Med 2:a012070
28. McClung CA, Nestler EJ (2008) Neuroplasticity mediated by altered gene expression. Neuropsychopharmacology 33:3–17
29. Meye FJ, van Zessen R, Smidt MP, Adan RAH, Ramakers GMJ (2012) Morphine withdrawal enhances constitutive ++-opioid receptor activity in the ventral tegmental area. J Neurosci 32:16120–16128
30. Nestler EJ (2001) Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2:119–128
31. Nestler EJ (2012) Transcriptional mechanisms of drug addiction. Clin Psychopharmacol Neurosci 10:136–143
32. Núñez C, Földes A, Pérez-Flores D, García-Borrón JC, Laorden ML, Kovács KJ, Milanés MV (2009) Elevated glucocorticoid levels are responsible for induction of tyrosine hydroxylase (TH) mRNA expression, phosphorylation and enzyme activity in the nucleus of the solitary tract (NTS-A2) during morphine withdrawal. Endocrinology 150:3118–3127
33. Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates, 6th edn. Academic Press, Amsterdam
34. Radke AK, Rothwell PE, Gevirtz JC (2011) An anatomical basis for opponent process mechanisms of opiate withdrawal. J Neurosci 31:7533–7539
35. Reddy SD, Rayala SK, Ohshiro K, Pakala SB, Kobori N, Dash P, Yun S, Qin J, O’Malley BW (2011) Multiple coregulatory control of tyrosine hydroxylase gene transcription. PNAS 108:4200–4205
36. Roeper J (2013) Dissecting the diversity of midbrain dopamine neurons. TINS 36:336–342
37. Sanchez-Simon FM, Zhang XX, Loh HH, Law PY, Rodriguez RE (2010) Morphine regulates dopaminergic neuron differentiation via miR-133b. Mol Pharmacol 78:935–942
38. Smidt MP, van Schaick HSA, Lanctôt C, Tremblay JJ, Cox JJ, van der Kleij AAM, Wolterink G, Drouin J, Burbach JP (1997) A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons. PNAS 94:13305–13310
39. Smidt MP, Asbreuk CH, Cox JJ, Chen H, Johnson RL, Burbach JP (2000) A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b. Nat Neurosci 3:337–341
40. Smidt MP, Smits SM, Burbach JP (2004) Homeobox gene Pitx3 and its role in the development of dopamine neurons of the substantia nigra. Cell Tissue Res 318:35–43
41. Smits SM, Smidt MP (2006) The role of Pitx3 in survival of midbrain dopaminergic neurons. J Neural Transm Suppl 70:57–60
42. Vogel C, Marcotte EM (2012) Insights into the regulation of protein abundance from proteomic and transcriptomic analysis. Nat Rev Genet 13:227–232
43. Volkow ND, Skolnick P (2012) New medications for substance use disorders: challenges and opportunities. Neuropsychopharmacology 37:290–292
44. Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F (2009) Imaging dopamine’s role in drug abuse and addiction. Neuropharmacology 56:3–8
45. Wang D, Raehal KM, Lin ET, Lowery JJ, Kieffer BL, Bilsky EJ, Sadée W (2004) Basal signaling activity of μ-opioid receptor in mouse brain: role in narcotic dependence. J Pharmacol Exp Ther 308:512–520
46. Zangen A, Ikemoto S, Zadina JE, Wise RA (2002) Rewarding and psychomotor stimulant effects of endomorphin-1: anteroposterior differences within the ventral tegmental area and lack of effect in nucleus accumbens. J Neurosci 22:7225–7233
47. Zinchuk V, Zinchuk O, Okada T (2007) Quantitative colocalization analysis of multicolor confocal immunofluorescence microscopy images: pushing pixels to explore biological phenomena. Acta Histochem Cytochem 40:101–111